Sri Lanka, is a rapidly developing island nation in the Indian subcontinent that has a population of nearly 20.5 million. Sri Lanka has seen huge investments in recent years.
Imports in Sri Lanka increased to 1585.50 USD Million in May from 1490.50 USD Million in April of 2015. Imports in Sri Lanka averaged 1070.58 USD Million from 2001 until 2015, reaching an all time high of 1986.40 USD Million in November - reported by the Central Bank of Sri Lanka.
In Sri Lanka, expenditure on healthcare has grown steadily. In the period 2005–10 Sri Lanka's total expenditure on health is estimated to have grown at a compound annual rate of around 11%, according to a local government think-tank, the Institute for Policy Studies. Private sector spending grew by 12% a year, while government spending increased by 10% a year in that period. Total spending on healthcare per head has risen from US$49 in 2005 to US$89 in 2012, according to the World Bank.
The President, Honorable Mahinda Rajapaksa, in his 2015 budget speech in October, claimed that the government spent SLRs150bn (US$1.2bn) providing universal healthcare.
The growth in both public and private healthcare, moreover, will increase the opportunities to export medical equipment and pharmaceuticals to the island. For example, US firms exported around US$15m worth of pharmaceuticals and medical equipment to Sri Lanka in 2013. The opportunities for exporting medical equipment are likely be greater because the government imposes prices controls on all imported medicines.
Healthcare: LKR282.9bn (USD2.2bn) in 2014 to LKR307.4bn (USD2.3bn) in 2015; +8.7% growth in local currency terms and 5.1% in US dollar terms.Market leaders in diagnostic labs are investing huge amount in Sri Lanka for estabilish new labs in the region.